Your account is not claimed yet. You can sign up with ORCID to claim your account.

Gamal Shiha

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 13

Top Venues

Journal of viral hepatitis

Liver international : official journal of the International Association for the Study of the Liver

Hepatology international

Alimentary pharmacology & therapeutics

Egyptian Liver Research Institute and Hospital (ELRIAH)

Mansoura University Faculty of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Egyptian Liver Research Institute and Hospital (ELRIAH)

Egypt

Founder and CEO

Education History

Mansoura University Faculty of Medicine

Egypt

PHD :: Internal medicine

Publications

Gamal Shiha, Nabiel Mikhail, Reham Soliman
Letter: comparison of clinical prediction rules for ruling out cirrhosis in non-alcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics 56 (6) (2022)
Gamal Shiha, Reham Soliman, Nabiel N H Mikhail, Fabrice Carrat, Jessica Azzi, Ganne-Carrié Nathalie, Hidenori Toyoda, Haruki Uojima, Akito Nozaki, Koichi Takaguchi, Atsushi Hiraoka, Masanori Atsukawa, Hiroshi Abe, Kentaro Matsuura, Shigeru Mikami, Tsunamasa Watanabe, Kunihiko Tsuji, Toru Ishikawa, Vithika Suri, Anu Osinusi, Liyun Ni, Jun Zou, Shiv Kumar Sarin, Manoj Kumar, Prasun Kumar Jalal, Mahmoud A Hashim, Manal Hassan, Sonia Alonso Lopez, Rafael Bañares, Adriana M Ahumada, Nasser Hamed Mousa, Mohammed Eslam, Imam Waked
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients. Journal of viral hepatitis 29 (9) (2022)
Gamal Shiha, N N H Mikhail, R Soliman
Reply to: The best predictive model for post-SVR HCC: can it be universal? Hepatology international 16 (3) (2022)
Gamal Shiha, Nabiel N H Mikhail, Reham Soliman
Letter: evaluation and proposed re-classification of HCC prediction model in patients with chronic hepatitis C genotype 4. Alimentary pharmacology & therapeutics 55 (2) (2022)
Gamal Shiha, Nabiel N H Mikhail, Reham Soliman, Ayman Hassan, Mohammed Eslam
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative study. Hepatology international 16 (1) (2022)
Gamal Shiha, Reham Soliman, Nabiel Mikhail, Ayman Hassan, Mohammed Eslam
Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk-based surveillance using pre- and post-treatment general evaluation score. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Wafaa Elzefzafy, Reham Soliman, Layla Saleh, Safyia Mahmoud, Nahed A Makhlouf, Gamal Shiha, Samy Zaky
Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, Egypt. Journal of viral hepatitis (2021)
Ahmed Nabil Ahmed, Koichiro Uto, Faten Zahran, Reham Soliman, Ayman A Hassan, Mohamed M Elshemy, Islam S Ali, Mitsuhiro Ebara, Gamal Shiha
The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs. BioMed research international 2021 (2021)
Gamal Shiha, Imam Waked, Reham Soliman, Mohamed Elbasiony, Asmaa I Gomaa, Nabiel N H Mikhail, Mohammed Eslam
GES: A validated simple score to predict the risk of HCC in patients with HCV-GT4-associated advanced liver fibrosis after oral antivirals. Liver international : official journal of the International Association for the Study of the Liver 40 (11) (2021)
Gamal Shiha, Nasser Hamed Mousa, Reham Soliman, Nabiel Nnh Mikhail, Mohamed Adel Elbasiony, Mahmoud Khattab
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study. Journal of viral hepatitis 27 (7) (2020)
Gamal Shiha, Reham Soliman, Abdalhamed Serwah, Nabiel N H Mikhail, Asselah Tarik, Philippa Easterbrook
A same day 'test and treat' model for chronic HCV and HBV infection: Results from two community-based pilot studies in Egypt. Journal of viral hepatitis 27 (6) (2020)
Gamal Shiha, Ahmed Nabil Ahmed, Ahmed Lotfy, Reham Soliman, Ayman A Hassan, Islam S Ali, Doaa F Gad, Faten Zahran
Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis. Stem cells international 2020 (2020)
Gamal Shiha, Reham Soliman, Nabiel Mikhail, Mohammed Eslam
Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-centre cohort of European cirrhotics. Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2020)

Gamal Shiha.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gamal Shiha